Brief: Seres Therapeutics Enters Into MOU For VOWST Asset Sale To Nestlé Health Science
06/06/2024 14:07
June 6 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS ENTERS INTO MEMORANDUM OF UNDERSTANDING
FOR
VOWST™ ASSET SALE TO NESTLÉ HEALTH SCIENCE
* SERES THERAPEUTICS INC: TO FULLY RETIRE ITS DEBT AND
EXTEND ITS
CASH RUNWAY INTO Q4 2025
Source text for Eikon: ID:nGNXj19s3
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47